Hydroxyzinum Hasco (Hydroxyzine Hydrochloride)

Hydroxyzine hydrochloride blocks histamine H1 receptors in peripheral tissues and the central nervous system. This antagonism reduces allergic inflammation, itching, and vasodilation, while its anticholinergic and central H1‑blocking actions produce sedation, anxiolysis, and anti‑emetic effects.

The dosage of Hydroxyzinum Hasco is determined by the prescribing clinician based on the patient’s age, condition, and response. The prescriber will set the appropriate strength, frequency, and duration according to clinical guidelines.

Hydroxyzine hydrochloride is classified as pregnancy category B1, indicating that animal studies have not shown risk but there are limited human data. It should be used only if the potential benefit outweighs any possible risk. Caution is also advised during breastfeeding, and a healthcare professional should be consulted.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Hydroxyzine offers both antihistaminic and sedative properties, making it useful for conditions where itching and anxiety coexist. Compared with non‑sedating antihistamines such as cetirizine, hydroxyzine provides stronger sedation and anxiolysis, but may cause more drowsiness and anticholinergic effects.

Hydroxyzinum Hasco should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. This helps maintain tablet integrity and potency throughout its shelf life.

Hydroxyzinum Hasco is taken orally as a tablet. It should be swallowed whole with water, unless the prescriber advises otherwise. The exact timing (e.g., with or without food) depends on the individual treatment plan.

Serious adverse reactions, although rare, include cardiac arrhythmias, severe hypotension, seizures, anaphylactic reactions, hepatic dysfunction, and blood dyscrasias such as agranulocytosis. Patients should seek immediate medical attention if they experience any of these symptoms.

Hydroxyzinum Hasco is contraindicated in patients with known hypersensitivity to hydroxyzine or any component of the formulation, and in individuals with severe QT prolongation or certain cardiac conduction disorders. Caution is also advised for patients with uncontrolled glaucoma, severe urinary retention, or significant hepatic impairment.